- Home
- ITRM vs RXO Comparison
ITRM vs RXO Comparison
Compare ITRM & RXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ITRM | RXO |
|---|---|---|
| Founded | 2015 | 2022 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.3M | 2.3B |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | ITRM | RXO |
|---|---|---|
| Price | $0.37 | $13.35 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 15 |
| Target Price | $9.00 | ★ $16.25 |
| AVG Volume (30 Days) | 664.5K | ★ 2.0M |
| Earning Date | 02-06-2026 | 02-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $390,000.00 | ★ $5,940,000,000.00 |
| Revenue This Year | N/A | $27.93 |
| Revenue Next Year | $325.95 | $3.52 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 53.85 |
| 52 Week Low | $0.36 | $10.43 |
| 52 Week High | $2.10 | $26.92 |
Technical Indicators
Market Signals| Indicator | ITRM | RXO |
|---|---|---|
| Relative Strength Index (RSI) | 32.04 | 44.74 |
| Support Level | $0.44 | $13.75 |
| Resistance Level | $0.49 | $16.00 |
| Average True Range (ATR) | 0.04 | 0.73 |
| MACD | -0.00 | -0.02 |
| Stochastic Oscillator | 6.22 | 0.79 |
Price Performance
Historical ComparisonAbout ITRM Iterum Therapeutics plc
Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.
About RXO RXO Inc.
RXO Inc is a brokered transportation platform defined by cutting-edge technology and a nimble, asset-light business model, with the component being core truck brokerage business. Its operations also include three asset-light, brokered transportation services, all of which complement its truck brokerage business: managed transportation, last mile and freight forwarding. The company operates into one reportable segment. The operates within the transportation industry and in the same geography North America.